Albert S. Baldwin
Impact in
- Cancer Research top 0.01%
- NF-κB Signaling Pathways
- Immunology top 0.05%
- Immune Response and Inflammation
- interferon and immune responses
- Immune Cell Function and Interaction
Papers in
- Cancer Research 155
- NF-κB Signaling Pathways 145
-
- Cell death mechanisms and regulation 34
- Natural product bioactivities and synthesis 16
- Epigenetics and DNA Methylation 15
- Co-authors
- Marty W. Mayo (23 shared papers)Cun-Yu Wang (7 shared papers)Patricia C. Cogswell (26 shared papers)Denis C. Guttridge (12 shared papers)Phillip A. Sharp (10 shared papers)Timothy S. Finco (7 shared papers)Amer A. Beg (10 shared papers)Bernd Stein (7 shared papers)
- Journals
- Molecular and Cellular Biology (31 papers)Journal of Biological Chemistry (28 papers)The Journal of Immunology (11 papers)Cancer Research (11 papers)Oncogene (8 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Albert S. Baldwin
239 papers receiving 42.5k citations
Albert S. Baldwin's Hit Papers
Peers
Comparison fields: 5 of 161
- Cancer Research 17.8k
- Immunology 14.5k
- Oncology 10.1k
- Molecular Biology 24.1k
- Toxicology 722
Countries citing papers authored by Albert S. Baldwin
This map shows the geographic impact of Albert S. Baldwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert S. Baldwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert S. Baldwin more than expected).
Fields of papers citing papers by Albert S. Baldwin
This network shows the impact of papers produced by Albert S. Baldwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert S. Baldwin. The network helps show where Albert S. Baldwin may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert S. Baldwin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 252 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | THE NF-κB AND IκB PROTEINS: New Discoveries and Insights Hit paper breakdown → | 1996 | 5367 |
| 2 | NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 Activation Hit paper breakdown → | 1998 | 2391 |
| 3 | TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB Hit paper breakdown → | 1996 | 2371 |
| 4 | NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 Hit paper breakdown → | 1999 | 1145 |
| 5 | Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Hit paper breakdown → | 1993 | 944 |
| 6 | Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB Hit paper breakdown → | 1999 | 889 |
| 7 | NF-κB-Induced Loss of MyoD Messenger RNA: Possible Role in Muscle Decay and Cachexia Hit paper breakdown → | 2000 | 763 |
| 8 | Akt Stimulates the Transactivation Potential of the RelA/p65 Subunit of NF-κB through Utilization of the IκB Kinase and Activation of the Mitogen-activated Protein Kinase p38 Hit paper breakdown → | 2001 | 686 |
| 9 | Characterization of Mechanisms Involved in Transrepression of NF-κB by Activated Glucocorticoid Receptors Hit paper breakdown → | 1995 | 680 |
| 10 | Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity Hit paper breakdown → | 1991 | 677 |
| 11 | Human CCAAT-binding proteins have heterologous subunits Hit paper breakdown → | 1988 | 666 |
| 12 | The p65 (RelA) Subunit of NF-κB Interacts with the Histone Deacetylase (HDAC) Corepressors HDAC1 and HDAC2 To Negatively Regulate Gene Expression Hit paper breakdown → | 2001 | 625 |
| 13 | Molecular cloning of an enhancer binding protein:Isolation by screening of an expression library with a recognition site DNA Hit paper breakdown → | 1988 | 593 |
| 14 | Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies Hit paper breakdown → | 2002 | 586 |
| 15 | Akt Suppresses Apoptosis by Stimulating the Transactivation Potential of the RelA/p65 Subunit of NF-κB Hit paper breakdown → | 2000 | 572 |
| 16 | Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression Hit paper breakdown → | 2006 | 570 |
| 17 | Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. Hit paper breakdown → | 1993 | 566 |
| 18 | NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced Apoptosis Hit paper breakdown → | 1999 | 521 |
| 19 | Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK Hit paper breakdown → | 2008 | 508 |
| 20 | 1993 | 484 |
About Albert S. Baldwin
Albert S. Baldwin is a scholar working on Cancer Research, Molecular Biology, Immunology, Oncology and Hematology, having authored 252 papers that have together received 43.3k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (145 papers), Cytokine Signaling Pathways and Interactions (51 papers), Immune Response and Inflammation (48 papers), Cell death mechanisms and regulation (34 papers), interferon and immune responses (34 papers), Immune Cell Function and Interaction (18 papers), Natural product bioactivities and synthesis (16 papers) and Epigenetics and DNA Methylation (15 papers). The work is most often cited by research in Cancer Research (17.8k citations), Immunology (14.5k citations), Oncology (10.1k citations), Molecular Biology (24.1k citations) and Toxicology (722 citations). Albert S. Baldwin has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Marty W. Mayo, Cun-Yu Wang, Patricia C. Cogswell, Denis C. Guttridge, Phillip A. Sharp, Timothy S. Finco, Amer A. Beg, Bernd Stein, Lee V. Madrid and Robert G. Korneluk. Their work appears in journals such as Molecular and Cellular Biology, Journal of Biological Chemistry, The Journal of Immunology, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.